Multidisciplinary symptom control clinic in a cancer center: a retrospective study

被引:70
作者
Bruera, E
Michaud, M
Vigano, A
Neumann, CM
Watanabe, S
Hanson, J
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Symptom Control & Palliat Care, Houston, TX 77030 USA
[2] Univ Alberta, Cross Canc Inst, Div Palliat Care Med, Edmonton, AB T6G 2M7, Canada
关键词
D O I
10.1007/s005200000172
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Our objective in this study was to review the characteristics, symptom intensity and satisfaction of patients referred to a half-day symptom control clinic (SCC) for advanced cancer patients. This was a retrospective study. The setting was a multidisciplinary symptom control clinic in a cancer centre. Those taking part were 166 consecutive advanced cancer patients referred to the half-day multidisciplinary SCC because of symptom distress. Patients referred to the clinic were assessed in a private room by a physician, a nurse, a pharmacist, a psychologist, and social, rehabilitation, nutrition. respiratory and pastoral care workers. Symptom distress (multiple visual analogue scales), cognition, and CAGE (alcoholism) were determined. Recommendations were given to the patient and sent to the oncologist, family physician and home care nurse. For 110 patients a second assessment was carried out 1 week later, and 64 patients underwent a telephone assessment 2 weeks after the second visit. Symptom intensity was determined during initial and follow-up visits, as well as during two follow-up telephone assessments. In addition, demographics and patient satisfaction with the SCC were determined. Overall symptom distress, depression, anxiety and sensation of wellbeing improved significantly from the first (n=166) to the second clinic visit (n=110). Further significant improvement was observed in overall symptom distress, pain, anxiety, sense of wellbeing and depression at the 2- (n=64) and 4-week (n=38) telephone follow-up assessments. Mean satisfaction with the SCC (0-10) was 7.7 +/- 2. Our findings suggest that the work of the SCC results in long-term effectiveness in symptom control and high levels of patient satisfaction. The SCC allows for better integration of care between a cancer center and community-based physicians and nurses. It also allows patients access to multiple disciplines that are not available outside tertiary centers.
引用
收藏
页码:162 / 168
页数:7
相关论文
共 25 条
[1]  
[Anonymous], CLIN AUDIT PALLIATIV
[2]  
AU H, 1995, R COLL PHYS SURG C S, V18, pB90
[3]   Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain [J].
Bruera, E ;
Belzile, M ;
Pituskin, E ;
Fainsinger, R ;
Darke, A ;
Harsanyi, Z ;
Babul, N ;
Ford, I .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) :3222-3229
[4]   Chronic nausea in advanced cancer patients: A retrospective assessment of a metoclopramide-based antiemetic regimen [J].
Bruera, E ;
Seifert, L ;
Watanabe, S ;
Babul, N ;
Darke, A ;
Harsanyi, Z ;
SuarezAlmazor, M .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1996, 11 (03) :147-153
[5]   The frequency of alcoholism among patients with pain due to terminal cancer [J].
Bruera, E ;
Moyano, J ;
Seifert, L ;
Fainsinger, RL ;
Hanson, J ;
SuarezAlmazor, M .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1995, 10 (08) :599-603
[6]   A PROSPECTIVE MULTICENTER ASSESSMENT OF THE EDMONTON STAGING SYSTEM FOR CANCER PAIN [J].
BRUERA, E ;
SCHOELLER, T ;
WENK, R ;
MACEACHERN, T ;
MARCELINO, S ;
HANSON, J ;
SUAREZALMAZOR, M .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1995, 10 (05) :348-355
[7]   A randomized, double-blind, double-dummy, crossover trial comparing the safety and efficacy of oral sustained-release hydromorphone with immediate-release hydromorphone in patients with cancer pain [J].
Bruera, E ;
Sloan, P ;
Mount, B ;
Scott, J ;
SuarezAlmazor, M .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (05) :1713-1717
[8]  
BRUERA E, 1990, Journal of Psychosocial Oncology, V8, P47, DOI 10.1300/J077v08n02_04
[9]  
BRUERA ED, 1994, CANCER, V74, P3204, DOI 10.1002/1097-0142(19941215)74:12<3204::AID-CNCR2820741220>3.0.CO
[10]  
2-G